BioNexus Gene Lab (BGLC) Preferred Shares (2018 - 2021)
BioNexus Gene Lab's (BGLC) quarterly Preferred Shares came in at $30.0 million in Q4 2021, little changed quarter-over-quarter from $30.0 million in Q2 2019.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) Preferred Shares (2018 - 2021) Analysis & Trends
BioNexus Gene Lab has disclosed Preferred Shares across 3 years of filings, most recently posting $30.0 million for Q4 2021.
- In Q4 2021, Preferred Shares changed N/A year-over-year to $30.0 million; the TTM figure through Dec 2021 stood at $30.0 million (changed N/A YoY), while the FY2021 annual figure was $30.0 million, changed N/A from the prior year.
- Preferred Shares came in at $30.0 million for Q4 2021 at BioNexus Gene Lab, roughly flat from $30.0 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $30.0 million in Q4 2018 to a low of $30.0 million in Q4 2018.
- Average Preferred Shares over 3 years is $30.0 million, with a median of $30.0 million recorded in 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 62.38 Bn | 62.17 Bn | 1.98 Bn | - |
| 2 | Fastenal | 56.92 Bn | 56.71 Bn | 1.06 Bn | - |
| 3 | Ferguson Enterprises | 44.34 Bn | 43.52 Bn | 2.32 Bn | - |
| 4 | Reliance | 20.45 Bn | 20.23 Bn | 1.30 Bn | - |
| 5 | Wesco International | 17.12 Bn | 16.31 Bn | 1.46 Bn | - |
| 6 | Applied Industrial Technologies | 11.98 Bn | 11.86 Bn | 411.22 Mn | - |
| 7 | Watsco | 11.22 Bn | 11.23 Bn | 578.93 Mn | - |
| 8 | Avantor | 10.13 Bn | 9.82 Bn | 537.00 Mn | - |
| 9 | Core & Main | 8.33 Bn | 8.25 Bn | 520.00 Mn | - |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 30.00 Mn |
| Jun 30, 2019 | 30.00 Mn |
| Dec 31, 2018 | 30.00 Mn |